Regen BioPharma Inc Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Regen BioPharma Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2012 to Q3 2024.
  • Regen BioPharma Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$265K, a 18.5% increase year-over-year.
  • Regen BioPharma Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$867K.
  • Regen BioPharma Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$867K, a 175% decline from 2023.
  • Regen BioPharma Inc annual Net Income (Loss) Attributable to Parent for 2023 was $1.16M, a 52.7% decline from 2022.
  • Regen BioPharma Inc annual Net Income (Loss) Attributable to Parent for 2022 was $2.44M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$867K -$265K +$60.1K +18.5% Jul 1, 2024 Sep 30, 2024 8-K 2024-11-29
Q2 2024 -$927K -$130K -$30.9K -31.1% Apr 1, 2024 Jun 30, 2024 8-K 2024-11-29
Q1 2024 -$896K -$122K -$67.5K -123% Jan 1, 2024 Mar 31, 2024 8-K 2024-11-29
Q4 2023 -$829K -$350K -$1.99M -121% Oct 1, 2023 Dec 31, 2023 8-K 2024-11-29
Q3 2023 $1.16M -$325K -$247K -317% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-20
Q2 2023 $1.4M -$99.2K -$67.1M -100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $68.5M -$55K +$67M +99.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 $1.43M $1.64M -$1.01M -38.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-01-19
Q3 2022 $2.44M -$78K +$1.31M +94.4% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-20
Q2 2022 $1.14M $67M +$74.4M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 -$73.3M -$67.1M -$67.5M -15271% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-18
Q4 2021 -$5.79M $2.64M +$979K +58.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-19
Q3 2021 -$6.77M -$1.38M -$2.59M -215% Jul 1, 2021 Sep 30, 2021 10-K 2022-11-15
Q2 2021 -$4.18M -$7.49M -$10.7M -334% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-22
Q1 2021 $6.52M $442K +$4.52M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-21
Q4 2020 $2M $1.67M -$1.42M -45.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-20
Q3 2020 $3.41M $1.2M -$667K -35.7% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-22
Q2 2020 $4.08M $3.21M +$7.61M Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-22
Q1 2020 -$3.53M -$4.08M -$3.74M -1124% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-18
Q4 2019 $215K $3.08M +$2.84M +1158% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-13
Q3 2019 -$2.62M $1.87M +$2.56M Jul 1, 2019 Sep 30, 2019 10-K 2021-08-04
Q2 2019 -$5.18M -$4.41M -$4.3M -3994% Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-05
Q1 2019 -$887K -$333K +$798K +70.5% Jan 1, 2019 Mar 31, 2019 10-Q 2021-08-05
Q4 2018 -$1.68M $245K +$3.03M Oct 1, 2018 Dec 31, 2018 10-Q 2021-08-05
Q3 2018 -$4.72M -$692K -$1.31M -211% Jul 1, 2018 Sep 30, 2018 10-K 2021-06-21
Q2 2018 -$3.4M -$108K +$2.52M +95.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-10-24
Q1 2018 -$5.92M -$1.13M +$181K +13.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-29
Q4 2017 -$6.1M -$2.79M -$261K -10.3% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-12
Q3 2017 -$5.84M $621K +$3.07M Jul 1, 2017 Sep 30, 2017 10-K 2018-12-27
Q2 2017 -$8.91M -$2.62M -$266K -11.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$8.64M -$1.31M -$221K -20.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$8.42M -$2.52M -$667K -35.9% Oct 1, 2016 Dec 31, 2016 10-Q 2017-01-27
Q3 2016 -$7.75M -$2.45M -$1.84M -307% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-21
Q2 2016 -$5.91M -$2.36M -$795K -50.9% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-01
Q1 2016 -$5.11M -$1.09M +$7.72M +87.6% Jan 1, 2016 Mar 31, 2016 10-Q 2016-04-29
Q4 2015 -$12.8M -$1.86M -$1.64M -747% Oct 1, 2015 Dec 31, 2015 10-Q 2017-01-27
Q3 2015 -$11.2M -$601K -$406K -209% Jul 1, 2015 Sep 30, 2015 10-K/A 2017-04-28
Q2 2015 -$10.8M -$1.56M -$1.4M -841% Apr 1, 2015 Jun 30, 2015 10-K/A 2017-04-28
Q1 2015 -$9.39M -$8.81M -$8.63M -4633% Jan 1, 2015 Mar 31, 2015 10-K/A 2017-04-28
Q4 2014 -$766K -$219K -$9.66K -4.61% Oct 1, 2014 Dec 31, 2014 10-Q/A 2017-04-28
Q3 2014 -$756K -$195K -$76.7K -65.1% Jul 1, 2014 Sep 30, 2014 10-K/A 2017-04-28
Q2 2014 -$680K -$166K -$91.2K -122% Apr 1, 2014 Jun 30, 2014 10-K/A 2017-04-28
Q1 2014 -$588K -$186K -$116K -164% Jan 1, 2014 Mar 31, 2014 10-K/A 2017-04-28
Q4 2013 -$473K -$210K -$118K -128% Oct 1, 2013 Dec 31, 2013 10-K/A 2017-04-28
Q3 2013 -$355K -$118K Jul 1, 2013 Sep 30, 2013 10-K 2014-12-18
Q2 2013 -$74.8K Apr 1, 2013 Jun 30, 2013 10-K 2014-12-18
Q1 2013 -$70.5K Jan 1, 2013 Mar 31, 2013 10-K 2014-12-18
Q4 2012 -$91.8K Oct 1, 2012 Dec 31, 2012 10-K 2014-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.